These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36815512)

  • 21. Bendamustine-Induced Nephrogenic Diabetes Insipidus in a Patient With AL Amyloidosis.
    Uwumugambi NA; Sanchorawala V; Shelton AC; Stern L; Gordon CE
    Am J Kidney Dis; 2017 Feb; 69(2):317-319. PubMed ID: 27780577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of AVPR2 variant in a neonate with congenital nephrogenic diabetes insipidus].
    Yu Y; Chen A; Zheng J; Chen L; Du L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1376-1379. PubMed ID: 33306826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.
    Fujimoto M; Okada S; Kawashima Y; Nishimura R; Miyahara N; Kawaba Y; Hanaki K; Nanba E; Kondo Y; Igarashi T; Kanzaki S
    Yonago Acta Med; 2014 Jun; 57(2):85-91. PubMed ID: 25324589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in daily urine solute output in patients with NDI, CDI, SIADH, and NSIAD: Clinical implications.
    Decaux G
    Clin Nephrol; 2021 Oct; 96(4):233-238. PubMed ID: 34236307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating Population Variants and Protein Structural Analysis to Improve Clinical Genetic Diagnosis and Treatment in Nephrogenic Diabetes Insipidus.
    Liao P; Xiang T; Li H; Fang Y; Fang X; Zhang Z; Cao Q; Zhai Y; Chen J; Xu L; Liu J; Tang X; Liu X; Wang X; Luan J; Shen Q; Chen L; Jiang X; Ma D; Xu H; Rao J
    Front Pediatr; 2021; 9():566524. PubMed ID: 33996673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital nephrogenic diabetes insipidus due to the mutation in
    Lin FT; Li J; Xu BL; Yang XX; Wang F
    World J Clin Cases; 2020 Dec; 8(24):6418-6424. PubMed ID: 33392325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rare Case of Congenital Diabetes Insipidus.
    Rege T; Polsani S; Jim B
    Front Med (Lausanne); 2015; 2():43. PubMed ID: 26217664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation of the arginine vasopressin receptor 2 gene in a patient with congenital nephrogenic diabetes insipidus.
    Tajima A; Miyata I; Katayama A; Toyoda S; Eto Y
    Clin Pediatr Endocrinol; 2005; 14(1):27-33. PubMed ID: 24790307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.
    Zhang M; Yu Q; Chen C; Han J; Cheng B; Tian D
    Medicine (Baltimore); 2019 Apr; 98(17):e15348. PubMed ID: 31027113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A de novo novel missense mutation in AVPR2 with severe nephrogenic diabetes insipidus.
    Kobayashi D; Nagaraj SK; Lin JJ; Bichet DG
    NDT Plus; 2010 Dec; 3(6):542-4. PubMed ID: 25949462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrogenic diabetes insipidus: a comprehensive overview.
    Vaz de Castro PAS; Bitencourt L; de Oliveira Campos JL; Fischer BL; Soares de Brito SBC; Soares BS; Drummond JB; Simões E Silva AC
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):421-434. PubMed ID: 35146976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel AVPR2 missense mutation in a Chinese boy with severe inherited nephrogenic diabetes insipidus.
    Huang L; Li W; Tang W; Lu G
    J Pediatr Endocrinol Metab; 2011; 24(9-10):807-9. PubMed ID: 22145481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel
    Li Q; Tian D; Cen J; Duan L; Xia W
    Front Endocrinol (Lausanne); 2021; 12():686818. PubMed ID: 34177810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrogenic Diabetes Insipidus.
    Kavanagh C; Uy NS
    Pediatr Clin North Am; 2019 Feb; 66(1):227-234. PubMed ID: 30454745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree.
    Bai Y; Chen Y; Kong X
    BMC Nephrol; 2018 Feb; 19(1):26. PubMed ID: 29394883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case Report: A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr273Met Mutation in Arginine Vasopressin Receptor 2.
    Huang L; Ma L; Li L; Luo J; Sun T
    Front Pediatr; 2021; 9():707452. PubMed ID: 34336746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational diabetes insipidus: Diagnosis and management.
    Ananthakrishnan S
    Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101384. PubMed ID: 32205050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeutic Option.
    Hashikawa R; Yamada H; Fujii T; Ohtsuru S
    Am J Case Rep; 2024 Apr; 25():e943244. PubMed ID: 38643357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
    Sahakitrungruang T; Tee MK; Rattanachartnarong N; Shotelersuk V; Suphapeetiporn K; Miller WL
    Horm Res Paediatr; 2010; 73(5):349-54. PubMed ID: 20389105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.